Gilead jumping on the Interferon is a BIG statement2 Aug 2020 15:51
for Synairgen. How much we don't quite know yet, but look like they are trying to collar the Vaccine-treatment part of the market, even if side effects are more common with IV. For sure Synarogen have collared the safest route to treatment and this is going to be huge in terms of treatment, effectiveness and overall market value.
Options are Fast track, fast track or possibly fast track. Covid won't pause and dither unlike Gov'ts and Peer reviews whilst helpful will overall endorse the treatment as effective with caveats.
We continue to await news with baited breath, even though we hope for the obvious fast track JV.